Amino-terminal pro-b-type natriuretic peptide in refractory kawasaki disease

Pediatric Cardiology

Volumn 30, Issue 6, 2009, Pages 837-839

  De Benedictis, Fernando Maria ^a   Colaneri, Massimo ^a   Osimani, Patrizia ^a   Bettuzzi, Maria Grazia ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Cardiac biomarkers; Infliximab

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE;

AORTA VALVE REGURGITATION; ARTICLE; CASE REPORT; CORONARY ARTERY ANEURYSM; HEART FAILURE; HUMAN; INFANT; MALE; MITRAL VALVE REGURGITATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 68449089445     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-009-9416-3     Document Type: Article

References (12)

1. JC Burns WH Mason SB Haugher 2005 Infliximab treatment for refractory Kawasaki syndrome J Pediatr 146 662 667
2. JC Burns BM Best A Mejas 2008 Infliximab treatment of immunoglobulin-resistant Kawasaki disease J Pediatr 153 833 838
3. FM de Benedictis B Lattanzi M Colaneri 2008 Home monitoring anticoagulation therapy in infants Arch Dis Child 93 714
4. MC Johns C Stephenson 2008 Amino-terminal pro-B-type natriuretic peptide testing in neonatal and pediatric patients Am J Cardiol 10 Suppl 76A 81A
5. T Kawamura M Wago H Kawaguchi M Tahara M Yuge 2000 Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease Pediatr Int 42 241 248
6. S Kurotobi N Kawakami K Shimizu 2005 Brain natriuretic peptide as hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease Pediatr Cardiol 26 425 430
7. KK Ma T Ogawa AJ deBold 2004 Selective upregulation of cardiac brain natriuretic peptide as the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase J Mol Cell Cardiol 36 505 513
8. T Matsubara S Furukawa K Yabuta 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions Clin Immunol Immunopathol 56 29 36
9. BW [tmp] McCrindle JS Li LL Minich 2007 Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements Circulation 116 174 179
10. MJ O'Connor FT Saulsbury 2007 Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab Clin Pediatr (Phila) 46 345 348
11. T Oishi M Fujieda T Shiraishi 2008 Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm Circ J 72 850 852
12. RV Williams VM Wilke LY Tani LL Minch 2002 Does abciximab enhance regression of coronary aneurysm resulting from Kawasaki disease? Pediatrics 109 1 E4